JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1990) 126, 473-481       DOI: 10.1677/joe.0.1260473
© 1990 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaidi, M.
Right arrow Articles by MacIntyre, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaidi, M.
Right arrow Articles by MacIntyre, I.

Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways

M. Zaidi, H. K. Datta, B. S. Moonga and I. MacIntyre

Calcitonin inhibits osteoclastic bone resorption and its action involves two separate acute effects on the osteoclast, both essential to the action of the hormone: abolition of cell motility (Q) and marked cellular retraction (R). The former was mimicked by dibutyryl cyclic AMP and cholera toxin and the latter by pertussis toxin, ionomycin and increases in ambient calcium. Aluminium fluoride ions produced both Q and R effects, while lithium prevented both. In addition, calcitonin elicited a biphasic elevation of cytosolic-free calcium in single isolated osteoclasts. We propose that the action of calcitonin is mediated by at least two G proteins, one responsible for the Q effect and the other for the R effect. In addition, two second messengers, cyclic AMP and calcium, are involved. These findings may help to explain the potency of calcitonin in inhibiting bone resorption, and may allow the rational design of new therapeutic agents designed to alter osteoclast behaviour.

Journal of Endocrinology (1990) 126, 473–481




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Marzia, R. Chiusaroli, L. Neff, N.-Y. Kim, A. H. Chishti, R. Baron, and W. C. Horne
Calpain Is Required for Normal Osteoclast Function and Is Down-regulated by Calcitonin
J. Biol. Chem., April 7, 2006; 281(14): 9745 - 9754.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Seck, M. Pellegrini, A. M. Florea, V. Grignoux, R. Baron, D. F. Mierke, and W. C. Horne
The {Delta}e13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling
Mol. Endocrinol., August 1, 2005; 19(8): 2132 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Villa, C. Dal Fiume, A. Maestroni, A. Rubinacci, F. Ravasi, and F. Guidobono
Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E627 - E633.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Santhanagopal, P. Chidiac, W. C. Horne, R. Baron, and S. J. Dixon
Calcitonin (CT) Rapidly Increases Na+/H+ Exchange and Metabolic Acid Production: Effects Mediated Selectively by the C1a CT Receptor Isoform
Endocrinology, October 1, 2001; 142(10): 4401 - 4413.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Samura, S. Wada, S. Suda, M. Iitaka, and S. Katayama
Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-{kappa}B Ligand and Macrophage Colony-Stimulating Factor
Endocrinology, October 1, 2000; 141(10): 3774 - 3782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Chen, J.-F. Shyu, A. Santhanagopal, D. Inoue, J.-P. David, S. J. Dixon, W. C. Horne, and R. Baron
The Calcitonin Receptor Stimulates Shc Tyrosine Phosphorylation and Erk1/2 Activation. INVOLVEMENT OF Gi, PROTEIN KINASE C, AND CALCIUM
J. Biol. Chem., July 31, 1998; 273(31): 19809 - 19816.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Kameda, H. Mano, T. Yuasa, Y. Mori, K. Miyazawa, M. Shiokawa, Y. Nakamaru, E. Hiroi, K. Hiura, A. Kameda, et al.
Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts
J. Exp. Med., August 18, 1997; 186(4): 489 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Shyu, D. Inoue, R. Baron, and W. C. Horne
The Deletion of 14Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C
J. Biol. Chem., December 6, 1996; 271(49): 31127 - 31134.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Arkett, S. Dixon, and S. Sims
Lamellipod extension and K+ current in osteoclasts are regulated by different types of G proteins
J. Cell Sci., January 2, 1994; 107(2): 517 - 526.
[Abstract] [PDF]


Home page
ScienceHome page
H. Lin, T. Harris, M. Flannery, A Aruffo, E. Kaji, A Gorn, L. Kolakowski Jr, H. Lodish, and Goldring SR
Expression cloning of an adenylate cyclase-coupled calcitonin receptor
Science, November 15, 1991; 254(5034): 1022 - 1024.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zhang, R. Baron, and W. C. Horne
Integrin Engagement, the Actin Cytoskeleton, and c-Src Are Required for the Calcitonin-induced Tyrosine Phosphorylation of Paxillin and HEF1, but Not for Calcitonin-induced Erk1/2 Phosphorylation
J. Biol. Chem., November 17, 2000; 275(47): 37219 - 37223.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Society for Endocrinology.